Gala Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Gala Therapeutics's estimated annual revenue is currently $2.8M per year.
- Gala Therapeutics's estimated revenue per employee is $251,000
Employee Data
- Gala Therapeutics has 11 Employees.
- Gala Therapeutics grew their employee count by -52% last year.
Gala Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Manager, Clinical Data Management | Reveal Email/Phone |
2 | Clinical Study Manager | Reveal Email/Phone |
3 | Clinical Research Associate II | Reveal Email/Phone |
4 | Research Engineer | Reveal Email/Phone |
5 | Administrative Assistant | Reveal Email/Phone |
Gala Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Gala Therapeutics?
Gala Therapeutics is a privately-held medical device company based in Menlo Park, CA that was formed by Apple Tree Partners (www.appletreepartners.com), a $1.5B healthcare-focused venture capital firm based in NYC. Gala is dedicated to developing disease modifying therapies that improve survival, quality of life, and outcomes for patients with lung cancer, COPD, asthma, and other pulmonary diseases. Gala is building a portfolio of technologies to address the needs of interventional pulmonologists, thoracic surgeons, and all physicians who treat pulmonary disease.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-52%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | -21% | N/A |
#2 | $1.7M | 11 | 22% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $1.4M | 11 | -15% | $51.5M |
#5 | $0.4M | 11 | -8% | $10M |